Call for Poster Abstracts – Fourth Annual Neurocritical Care Conference

We cordially invite you to submit a poster abstract for display at the Fourth Annual Neurocritical Care Conference on Thursday, October 27, 2022 at the University Conference Center, Hershey, PA. You may submit more than one abstract.

The abstract submission deadline is Aug. 10, 2022.  

Posters can be research based or related to evidence-based practice and practice improvement. Posters must be Neurosciences related. 

Health professionals who submit an abstract should receive a confirmation within 48 hours. If you have submitted an abstract but have not yet received a confirmation, please email Dawn Gesford at and copy to 
Jacquelyn Ryer at

To submit a poster abstract:

Step 1: Prepare the abstract in Microsoft Word listing Title, Authors, Introduction, Methods, Results, Conclusions. Final abstracts must fit on one standard US 8.5 x 11-inch sheet of paper. Abstracts should be double spaced, 12 font and allow one-inch margins on all sides. Abstracts will be reproduced exactly as submitted.

Step 2: Submit abstract as a .doc, .txt or .pdf file using the form below.

Abstracts that do not include all information will not be reviewed.
Presenting Author
Please enter the information below concerning the presenting author(s) of the abstract. The presenting author must submit all required contact information and complete the section on disclosure of financial relationships.  The Accreditation Council for Continuing Medical Education requires that CME providers identify and resolve any potential conflict of interest related to educational content. Abstract submissions will not be considered if disclosure is not provided.

By submitting an abstract, you are agreeing that if it is accepted, you are willing to pay the conference registration fee to attend the conference and responsible to create the poster, no more than 4ft high by 6ft wide. 
Financial Disclosure and Agreement
Penn State College of Medicine is committed to presenting CME activities that promote improvements or quality in health care and are developed free of the control of ineligible companies (formerly known as a commercial interest). It is our policy to ensure that our activities are balanced, independent, objective, scientific, and in compliance with regulatory requirements. Anyone who is in a position to control the content of a CME presentation (course directors, faculty, planning committees, etc.) is expected to disclose all financial relationships with ineligible companies. The information listed on this form will be used to assess and mitigate any potential conflict of interest you may have, and will be disclosed to the audience of the CME activity. Faculty/planners who refuse to disclose will be disqualified from participating in this CME activity.

Please disclose all financial relationships that you have had in the past 24 months with ineligible companies (see definition below). For each financial relationship, enter the name of the ineligible company and the nature of the financial relationship(s). There is no minimum financial threshold; we ask that you disclose all financial relationships, regardless of the amount, with ineligible companies. You should disclose all financial relationships regardless of the potential relevance of each relationship to the education.

The ACCME defines an ineligible company as any entity whose primary business is producing, marketing, selling, re‐selling, or distributing healthcare products used by or on patients. The ACCME does not consider providers of clinical services directly to patients to be an ineligible company.

The ACCME Standards for Integrity and Independence require that we disqualify individuals who refuse to provide this information from involvement in the planning and implementation of accredited continuing education.

Disclosure of speaker relationship to ineligible companies information (if applicable)

Additional Information

I attest to the following:

I agree to the following:

Abstract Information

Electronic Signature
By submitting this form, I am providing my electronic signature approving all of the information submitted.